Testing and diagnosis of hepatitis C virus (HCV) infection is the gateway for access to both
treatment and prevention services, and crucial for an effective hepatitis epidemic response …

Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …

With no approved pharmacological treatment, nonalcoholic fatty liver disease (NAFLD) is
now the most common cause of chronic liver disease in Western countries and its worldwide …

Background: Sofosbuvir and ledipasvir, which have recently been approved for treatment of
chronic hepatitis C virus (HCV) infection, are more efficacious and safer than the old …

Chinese translation Description: Update of the 2004 US Preventive Services Task Force
(USPSTF) recommendation on screening for and treatment of hepatitis C virus (HCV) …

Abstract Background Hepatitis C virus (HCV) infection represents a major public health
burden with diverse epidemics worldwide, but at present, only a minority of infected persons …

Background: The prevalence of hepatitis C virus (HCV) in US prisoners is high; however,
HCV testing and treatment are rare. Infected inmates released back into society contribute to …

Background. New hepatitis C virus (HCV) treatments deliver higher cure rates with fewer
contraindications, increasing demand for treatment and healthcare costs. The cost …

Background & Aims In Europe, hepatitis C virus (HCV) screening still targets people at high
risk of infection. We aim to determine the cost-effectiveness of expanded HCV screening in …

Background: Prevalence of chronic hepatitis C virus (HCV) infection is high among
incarcerated persons in the United States. New, short-duration, high-efficacy therapies may …